Skip to main content
. 2020 Jun 20;18(6):325. doi: 10.3390/md18060325

Figure 5.

Figure 5

3D bioprinting of patches. Appearance of 3D-printed patches (a) without or (b) with PEGylated liposomal doxorubicin before UV irradiation. The printer ink contained 10% F-GelMA and 7% CMC.